(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Targeted disruption of Isl1 results in the developmental loss
of RGCs. (A-H) Immunostaining of retina sections with anti-BRN3B
reveals a significant loss of BRN3B+ RGCs in Isl1 nulls at E17.5
(C,G) and E18.5 (D,H). Insets show the enlarged views of the central retina.
(I,J) Anti-activated caspase3 immunostaining shows an increase
in apoptotic cells (arrows) in the GCL of Isl1-null retina.
(K) The difference of apoptotic cell numbers in wild-type and
Isl1-null retina is insignificant at E13.5-15.5. However, in
Isl1 nulls, the apoptotic cells are significantly increased from
E16.5. Each histogram represents the mean+s.d. n=3 or 4 for each
genotype per stage. *P<0.05,
**P<0.01; t-test. R, retina; L, lens; NBL,
neuroblast layer; GCL, ganglion cell layer. Scale bars: 100 µm in A-D; 25
µm in I.